Nuvation Bio Inc - Class A (NUVB) Stock Price

2.30 ▼ -0.04 (-1.71%)
Open: 2.42 Vol: 4.79M Day's range: 2.29 - 2.5499 Aug 08, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NUVB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.31▼ 2.35▼ 2.35▼ 2.33▼ 2.31▼
MA10 2.32▼ 2.36▼ 2.35▼ 2.37▼ 2.17▲
MA20 2.34▼ 2.35▼ 2.33▼ 2.35▼ 2.13▲
MA50 2.36▼ 2.34▼ 2.33▼ 2.21▲ 2.37▼
MA100 2.36▼ 2.34▼ 2.40▼ 2.12▲ 2.30▲
MA200 2.33▼ 2.40▼ 2.29▲ 2.31▼ 2.97▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.005▼ -0.007▼ -0.001▼ -0.020▼ 0.047▲
RSI 34.126▼ 43.092▼ 45.773▼ 50.011▲ 51.382▲
STOCH 10.596▼ 23.194     25.971     20.815     60.192    
WILL %R -93.333▼ -98.000▼ -73.134     -80.702▼ -38.655    
CCI -88.270     -164.110▼ -128.324▼ -23.483     70.592    
Latest Filters Detected On NUVB
MA $NUVB Price Crossed Below MA(200) Set Alert
MA $NUVB Price Crossed Below MA(26) Set Alert
MA $NUVB Price Crossed Below MA(7) Set Alert
▲ GAP $NUVB Open Gap Up %3 Set Alert
▲ GAP $NUVB Open Gap Up %2 Set Alert
CDL $NUVB Engulfing Candlestick Pattern Detected Set Alert
Nuvation Bio Inc - Class A News
Nuvation Bio To Present New Data on IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses
Saturday, August 09, 2025 11:00 AM
Detailed price information for Nuvation Bio Inc (NUVB-N) from The Globe and Mail including charting and trades.
NUVB Sales Jump 1,043% on Drug Launch
Thursday, August 07, 2025 10:40 AM
FDA approval of IBTROZI (taletrectinib) transformed Nuvation Bio into a commercial-stage company, driving $4.8 million in GAAP revenue, well above GAAP revenue estimates. Earnings per share (GAAP) was ...
Nuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
Thursday, August 07, 2025 04:41 AM
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company tackling some of the toughest challenges in cancer treatment, today reported financial results for the second quarter ended June 30, 2025, and ...
NUVB historical stock data
date open high low close volume
08/08/25 2.42 2.5499 2.29 2.30 4,788,519
07/08/25 2.33 2.50 2.19 2.34 4,844,229
06/08/25 2.38 2.38 2.25 2.35 4,649,310
05/08/25 2.33 2.41 2.26 2.37 2,433,179
04/08/25 2.24 2.31 2.22 2.31 3,047,565
01/08/25 2.28 2.32 2.22 2.23 3,602,077
31/07/25 2.34 2.455 2.33 2.36 2,614,144
30/07/25 2.47 2.555 2.35 2.41 3,312,312
29/07/25 2.55 2.58 2.425 2.46 4,492,675
28/07/25 2.52 2.76 2.515 2.55 5,888,658
Quote Details
52wk Low:1.54
52wk High:3.455
Vol:4.79M
Avg Vol(3m):105.1M
1Y Chng:-20.14%
1M Chng:+19.17%
Add to Watch List
More Information
Index N/A
Market Cap. 796.22M